Ophthalmic Genetic Test
Helping Pharma companies develop Precision medicine using Clinical Data & AI.
What is an Ophthalmic Genetic Test?
GeneHealth’s Ophthalmic Genetic Test analyzes a patient’s DNA to identify specific genetic mutations linked to hereditary ocular disorders. Utilizing highly advanced Next-Generation Sequencing (NGS) and MLPA techniques, this test precisely detects pathogenic variants. It empowers ophthalmologists to confirm clinical diagnoses, predict disease progression, and formulate highly tailored therapeutic interventions.
Book a Test Now →Understanding the Genetics of Ophthalmic Disorders
| Genetic Category | Clinical Description & Examples |
|---|---|
| Monogenic Disorders | Hundreds of inherited disorders affecting various segments of the eye. These are typically caused by autosomal dominant, autosomal recessive, or X-linked mutations exhibiting significant genetic and clinical heterogeneity. |
| Complex / Polygenic | Multifactorial diseases driven by a combination of genetic and non-genetic factors. Population-specific variants strongly contribute to overall disease risk. Examples: Glaucoma, age-related macular degeneration (AMD), and specific cataracts. |
| Common Genetic Conditions |
Monogenic: Corneal dystrophies, Albinism, Norrie disease, retinoblastoma, inherited optic neuropathies, and colour vision deficiencies. Developmental: Anterior segment dysgenesis, aniridia, and microphthalmos. Complex: Keratoconus, Fuchs endothelial corneal dystrophy, pseudoexfoliation syndrome, and diabetic retinopathy. |
Clinical Applications
- Enables highly accurate and definitive diagnosis of complex inherited eye conditions.
- Identifies potential targeted treatment options based on molecular findings (e.g., matching patients to FDA-approved gene therapies like Luxturna for biallelic RPE65 mutations).
- Assists in assessing the risk of disease in other family members through cascade screening.
- Aids physicians in estimating disease severity and anticipating potential systemic involvement early on.
- Guides reproductive planning and facilitates recurrence risk assessment in prenatal settings.
Assay Specifications
14 working days for MLPA.
Key Highlights of GeneHealth’s Ophthalmic Genetic Test
Our genetic testing enables the early identification of inherited eye disorders, allowing for timely intervention and significantly better long-term disease management.
Comprehensively analyzes over 720+ critical genes strictly associated with a wide spectrum of inherited ophthalmic and developmental eye conditions.
Goes beyond standard testing by successfully detecting clinically relevant variants located within regulatory and deep intronic genomic regions.
